Agenus Stock (NASDAQ: AGEN) stock price, news, charts, stock research, profile.
Open | $8.600 |
Close | $11.690 |
Volume / Avg. | 3.367M / 673.348K |
Day Range | 8.450 - 12.230 |
52 Wk Range | 4.775 - 42.600 |
Market Cap | $246.744M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 63 |
Short Interest | 229.66% |
Days to Cover | 7.43 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Agenus (NASDAQ: AGEN) through any online brokerage.
Other companies in Agenus’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Innate Pharma (NASDAQ:IPHA), bluebird bio (NASDAQ:BLUE), Atossa Therapeutics (NASDAQ:ATOS) and Adicet Bio (NASDAQ:ACET).
The latest price target for Agenus (NASDAQ: AGEN) was reported by B. Riley Securities on Monday, March 18, 2024. The analyst firm set a price target for 5.00 expecting AGEN to fall to within 12 months (a possible -57.56% downside). 10 analyst firms have reported ratings in the last year.
The stock price for Agenus (NASDAQ: AGEN) is $11.78 last updated April 26, 2024 at 7:56 PM EDT.
There are no upcoming dividends for Agenus.
Agenus’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Agenus.
Agenus is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.